Technical Analysis for INSM - Insmed, Inc.

Grade Last Price % Change Price Change
grade B 28.21 -3.29% -0.96
INSM closed down 3.29 percent on Friday, March 22, 2019, on 71 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Down
See historical INSM trend table...

Date Alert Name Type % Chg
Mar 22 Bollinger Band Squeeze Range Contraction 0.00%
Mar 22 NR7 Range Contraction 0.00%
Mar 22 BB Squeeze + Lower Band Touch Range Contraction 0.00%
Mar 22 Below Lower BB Weakness 0.00%
Mar 22 Lower Bollinger Band Touch Weakness 0.00%
Mar 22 Oversold Stochastic Weakness 0.00%
Mar 21 20 DMA Resistance Bearish -3.29%
Mar 21 Bullish Engulfing Bullish -3.29%
Mar 21 Bollinger Band Squeeze Range Contraction -3.29%
Mar 21 Stochastic Reached Oversold Weakness -3.29%

Older signals for INSM ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Insmed Incorporated, a biopharmaceutical company, focuses on developing and commercializing targeted inhalation therapies for patients battling serious lung diseases. Its lead candidate ARIKACE is engineered to deliver a proven and potent anti-infective directly to the site of serious lung infections to improve the treatment for two identified patient populations comprising cystic fibrosis (CF) patients with Pseudomonas aeuruginosa lung infections and patients with nontuberculous mycobacteria lung infections (NTM). The company's Phase III registrational study of ARIKACE in CF patients in Europe and Canada has completed enrollment; and Phase II clinical trial in NTM patients is under way with clinical results. Insmed Incorporated was founded in 1999 and is headquartered in Monmouth Junction, New Jersey.
Biopharmaceutical Medical Specialties Infectious Diseases Cystic Fibrosis Microbiology Infectious Causes Of Cancer Bacterial Diseases Bacteriology Pseudomonas Tuberculosis
Is INSM a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 5 bullish, 0 bearish and 0 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 31.58
52 Week Low 11.31
Average Volume 908,698
200-Day Moving Average 21.7876
50-Day Moving Average 26.6692
20-Day Moving Average 29.687
10-Day Moving Average 29.697
Average True Range 1.3139
ADX 31.63
+DI 19.4572
-DI 16.3854
Chandelier Exit (Long, 3 ATRs ) 27.5583
Chandelier Exit (Short, 3 ATRs ) 28.8217
Upper Bollinger Band 31.1546
Lower Bollinger Band 28.2194
Percent B (%b) 0.0
BandWidth 9.887156
MACD Line 0.7683
MACD Signal Line 1.2165
MACD Histogram -0.4481
Fundamentals Value
Market Cap 1.76 Billion
Num Shares 62.4 Million
EPS -3.04
Price-to-Earnings (P/E) Ratio -9.28
Price-to-Sales 0.00
Price-to-Book 20.05
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 29.41
Resistance 3 (R3) 29.54 29.27 29.21
Resistance 2 (R2) 29.27 28.96 29.21 29.14
Resistance 1 (R1) 28.74 28.78 28.61 28.61 29.08
Pivot Point 28.47 28.47 28.40 28.41 28.47
Support 1 (S1) 27.94 28.16 27.81 27.81 27.34
Support 2 (S2) 27.67 27.98 27.61 27.28
Support 3 (S3) 27.14 27.67 27.21
Support 4 (S4) 27.01